BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20686833)

  • 41. Baseline bone mineral density of the total lumbar spine may predict for chemotherapy-induced ovarian failure.
    Shapiro CL; Phillips G; Van Poznak CH; Jackson R; Leboff MS; Woodard S; Lemeshow S
    Breast Cancer Res Treat; 2005 Mar; 90(1):41-6. PubMed ID: 15770525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteoporosis after adjuvant treatment for early-stage breast cancer.
    Christensen CØ; Jensen MB; Hermann AP; Ewertz M
    Dan Med J; 2020 Oct; 67(11):. PubMed ID: 33215600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment.
    Hershman DL; McMahon DJ; Crew KD; Shao T; Cremers S; Brafman L; Awad D; Shane E
    J Clin Endocrinol Metab; 2010 Feb; 95(2):559-66. PubMed ID: 20022990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Diphosphonates on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer.
    Wu C; Chen W; Huang X; Lin R; Wu J; Zhang X
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1243-e1250. PubMed ID: 30146230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.
    Shapiro CL; Halabi S; Hars V; Archer L; Weckstein D; Kirshner J; Sikov W; Winer E; Burstein HJ; Hudis C; Isaacs C; Schilsky R; Paskett E
    Eur J Cancer; 2011 Mar; 47(5):683-9. PubMed ID: 21324674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients.
    Kim M; Kim H; Ahn SH; Tabatabaie V; Choi SW; Sohn G; Lee SB; Ko BS; Chung IY; Kim J; Lee JW; Son BH; Kim HJ
    Breast Cancer Res Treat; 2020 Apr; 180(3):657-663. PubMed ID: 32072339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
    Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
    Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in Bone Mineral Density in Women With Breast Cancer: A Prospective Cohort Study.
    Kim SH; Cho YU; Kim SJ; Han MS
    Cancer Nurs; 2019; 42(2):164-172. PubMed ID: 30802224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer.
    Oostra DR; Lustberg MB; Reinbolt RE; Pan X; Wesolowski R; Shapiro CL
    Mol Cell Endocrinol; 2015 Feb; 402():51-6. PubMed ID: 25575458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation study between osteoporosis and hematopoiesis in the context of adjuvant chemotherapy for breast cancer.
    Schyrr F; Wolfer A; Pasquier J; Nicoulaz AL; Lamy O; Naveiras O
    Ann Hematol; 2018 Feb; 97(2):309-317. PubMed ID: 29170810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.
    Wenners A; Grambach J; Koss J; Maass N; Jonat W; Schmutzler A; Mundhenke C
    BMC Cancer; 2017 Sep; 17(1):632. PubMed ID: 28877720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study.
    Loo WT; Jin LJ; Cheung MN; Chow LW; Wang M
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S109-15. PubMed ID: 20374022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Prospective Observational Study on Effect of Short-Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO-01).
    Nakamura M; Ishiguro A; Muranaka T; Fukushima H; Yuki S; Ono K; Murai T; Matsuda C; Oba A; Itaya K; Sone T; Yagisawa M; Koike Y; Endo A; Tsukuda Y; Ono Y; Kudo T; Nagasaka A; Nishikawa S; Komatsu Y
    Oncologist; 2017 May; 22(5):592-600. PubMed ID: 28341762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic and environmental influences on bone mineral density in pre- and post-menopausal women.
    Brown LB; Streeten EA; Shapiro JR; McBride D; Shuldiner AR; Peyser PA; Mitchell BD
    Osteoporos Int; 2005 Dec; 16(12):1849-56. PubMed ID: 15997421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
    Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
    Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer.
    Tabatabai LS; Bloom J; Stewart S; Sellmeyer DE
    J Womens Health (Larchmt); 2019 Jan; 28(1):87-92. PubMed ID: 30312118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for osteoporosis: prevalence, change, and association with bone density.
    Guthrie JR; Ebeling PR; Dennerstein L; Wark JD
    Medscape Womens Health; 2000; 5(5):E2. PubMed ID: 11113775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients.
    Monroy-Cisneros K; Esparza-Romero J; Valencia ME; Guevara-Torres AG; Méndez-Estrada RO; Anduro-Corona I; Astiazarán-García H
    BMC Cancer; 2016 Nov; 16(1):860. PubMed ID: 27821086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
    Reh A; Oktem O; Oktay K
    Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.